HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuichiro Ohe Selected Research

Palliative Care (Palliative Therapy)

4/2022Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme.
11/2020Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuichiro Ohe Research Topics

Disease

187Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 02/2002
135Neoplasms (Cancer)
04/2024 - 01/2002
47Lung Neoplasms (Lung Cancer)
06/2023 - 05/2002
27Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2023 - 05/2002
26Disease Progression
04/2024 - 07/2006
17Neutropenia
12/2020 - 02/2005
16Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 07/2004
14Thymoma (Thymic Carcinoma)
04/2024 - 05/2015
13Adenocarcinoma of Lung
05/2024 - 02/2007
13Neoplasm Metastasis (Metastasis)
07/2023 - 05/2007
11Diarrhea
12/2022 - 05/2007
10Adenocarcinoma
01/2023 - 05/2002
9Carcinoma (Carcinomatosis)
01/2022 - 08/2005
7Pneumonia (Pneumonitis)
02/2024 - 01/2012
7Febrile Neutropenia
12/2020 - 10/2015
6Exanthema (Rash)
01/2022 - 09/2009
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 12/2009
5Malignant Mesothelioma
06/2021 - 06/2019
5Radiation Pneumonitis
01/2021 - 07/2006
5Drug-Related Side Effects and Adverse Reactions
08/2020 - 03/2007
5Thrombocytopenia (Thrombopenia)
01/2020 - 12/2009
4Fever (Fevers)
11/2023 - 02/2004
4Hypertension (High Blood Pressure)
12/2022 - 01/2020
4Anemia
01/2020 - 08/2006
3Cachexia
01/2023 - 01/2014
3Adrenal Insufficiency (Adrenal Gland Hypofunction)
11/2022 - 01/2019
3Lymphoma (Lymphomas)
01/2022 - 10/2006
3Vomiting
04/2021 - 10/2018
3Nausea
04/2021 - 10/2018
3Infections
01/2021 - 07/2012
3Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 06/2010
3Fatigue
10/2020 - 10/2006

Drug/Important Bio-Agent (IBA)

42ErbB Receptors (EGF Receptor)IBA
02/2024 - 10/2005
39NivolumabIBA
01/2024 - 01/2016
38Cisplatin (Platino)FDA LinkGeneric
01/2023 - 02/2002
36Tyrosine Kinase InhibitorsIBA
04/2024 - 10/2006
31PlatinumIBA
01/2024 - 05/2002
26Gefitinib (Iressa)FDA Link
04/2019 - 05/2002
22osimertinibIBA
02/2024 - 04/2015
21Carboplatin (JM8)FDA LinkGeneric
01/2023 - 01/2008
20Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 12/2003
17Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2011
17Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 01/2002
16pembrolizumabIBA
04/2024 - 01/2017
16Immune Checkpoint InhibitorsIBA
01/2024 - 01/2016
16B7-H1 AntigenIBA
10/2023 - 05/2015
13Docetaxel (Taxotere)FDA Link
01/2023 - 02/2002
12LigandsIBA
12/2023 - 05/2015
10Etoposide (VP 16)FDA LinkGeneric
01/2023 - 05/2002
10amrubicinIBA
11/2019 - 09/2010
10Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2019 - 10/2005
9CrizotinibIBA
07/2023 - 06/2013
9Alanine Transaminase (SGPT)IBA
10/2022 - 12/2003
9alectinibIBA
05/2022 - 06/2013
8Monoclonal AntibodiesIBA
10/2023 - 01/2016
8durvalumabIBA
10/2023 - 01/2020
7IpilimumabIBA
01/2024 - 01/2022
7Pemetrexed (MTA)FDA Link
08/2023 - 07/2008
7Anaplastic Lymphoma KinaseIBA
07/2023 - 02/2016
6Proteins (Proteins, Gene)FDA Link
10/2023 - 02/2007
6Bevacizumab (Avastin)FDA Link
01/2023 - 12/2016
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2022 - 01/2019
5AntibodiesIBA
04/2024 - 12/2015
5GemcitabineFDA Link
04/2021 - 02/2002
4Phosphotransferases (Kinase)IBA
04/2024 - 12/2015
4brigatinibIBA
09/2023 - 12/2022
4Antineoplastic Agents (Antineoplastics)IBA
07/2022 - 08/2006
4AntiemeticsIBA
04/2022 - 10/2018
4Cytochrome P-450 CYP3AIBA
04/2022 - 02/2005
4CytokinesIBA
02/2022 - 01/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 07/2006
4DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2012
3lenvatinibIBA
04/2024 - 01/2020
3Programmed Cell Death 1 ReceptorIBA
10/2023 - 10/2018
3RamucirumabIBA
01/2023 - 01/2016
3Cell-Free Nucleic AcidsIBA
11/2022 - 01/2012
3selpercatinibIBA
10/2022 - 01/2020
3Aprepitant (Emend)FDA Link
04/2022 - 01/2020
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 02/2016
3SteroidsIBA
05/2021 - 07/2006
3130-nm albumin-bound paclitaxelIBA
04/2021 - 06/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 04/2002
3Olanzapine (Zyprexa)FDA Link
01/2020 - 08/2016
3amrubicinolIBA
11/2019 - 04/2012
3Cadherins (E-Cadherin)IBA
08/2015 - 06/2012
3Vinorelbine (Navelbine)FDA LinkGeneric
02/2012 - 08/2004
3Hemoglobins (Hemoglobin)IBA
06/2010 - 08/2006
2Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 02/2004
2Formaldehyde (Formol)FDA Link
08/2023 - 02/2016
2ParaffinIBA
08/2023 - 02/2016

Therapy/Procedure

88Therapeutics
03/2024 - 07/2004
79Drug Therapy (Chemotherapy)
01/2024 - 02/2002
32Radiotherapy
02/2023 - 07/2004
27Chemoradiotherapy
10/2023 - 08/2003
11Immunotherapy
04/2024 - 05/2015
6Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 12/2004
5Adjuvant Chemotherapy
01/2023 - 05/2016
4Aftercare (After-Treatment)
11/2023 - 12/2013
4Molecular Targeted Therapy
10/2022 - 12/2015
2Surgical Instruments (Clip)
06/2023 - 01/2023